Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Honore, Patrick M.
Barreto Gutierrez, Leonel
De Bels, David
Text and Data Mining valid from 2019-12-01
Version of Record valid from 2019-12-12
5 October 2019
29 November 2019
12 December 2019
Ethics approval and consent to participate
The authors declare that they have no competing interests.